Jammu, 20th May 2024: The Surgical Oncology team at American Oncology Institute (AOI) in Jammu has achieved a significant milestone by performing a highly innovative procedure for an advanced stage ovarian cancer. This technique, known as Hyperthermic Intra-peritoneal Chemotherapy (HIPEC), is an advanced cancer treatment that requires skilled surgeons and state-of-the-art equipment.
The procedure was successfully carried out by the Surgical Oncology team at AOI Jammu, led by Dr Avinash Rajra and Dr Sujeet Bhat, with the proficient support of the anesthesia team comprising Dr Atul Sharma and Dr Khuram Malik.
The patient, a 56-year-old female with ovarian cancer, underwent a thorough evaluation and was counseled for HIPEC. The procedure was executed in two stages. In the first stage, Dr Avinash Rajra and his team meticulously removed the entire tumor. In the second stage, chemotherapy drugs were infused into the abdomen, maintained for 90 minutes, and then evacuated through an outflow valve.
The patient's postoperative course was uneventful, and she was discharged on the fifth postoperative day. She is currently recovering well at home, expressing satisfaction with the outcome of the surgery.
HIPEC improves long-term outcomes for patients, effectively targeting cancer cells in the abdomen with fewer side effects than traditional chemotherapy. Discussing the procedure, Dr Avinash Rajra stated, "We are very pleased to expand the scope of our surgical oncology services and bring this advanced level of care to our region and our patients."
Dr Neeraj Bishnoi, RCOO of AOI Jammu, added, "The successful implementation of the HIPEC procedure at our facility is a testament to our team's dedication and expertise. At AOI, we strive to stay at the forefront of medical advancements to provide our patients with the best possible care. The introduction of HIPEC is a significant step forward in our mission to offer comprehensive and effective cancer treatments. We are proud of our surgical oncology team for their meticulous approach and for setting a new standard in cancer care within the region. This procedure enhances the quality of life of our patients by minimizing the side effects associated with conventional chemotherapy. Our commitment to innovation and excellence in healthcare remains unwavering, and we will continue to invest in advanced technologies and training to ensure our patients receive the highest standard of care."
